Board Meeting25 Sept 2026, 06:10 pm
Dr. Lal PathLabs Board Meeting Nov 4 for Q2 FY27 Results
AI Summary
Dr. Lal PathLabs Ltd has announced a Board of Directors meeting scheduled for November 4, 2026. The primary agenda is to consider and approve the un-audited financial results for both standalone and consolidated operations for the quarter and half-year ending September 30, 2026. Concurrently, the company will implement a trading window closure from October 1, 2026, to November 6, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading during the blackout period.
Key Highlights
- Board meeting scheduled for November 4, 2026.
- To approve un-audited financial results for Q2 FY27.
- Trading window closed from October 1 to November 6, 2026.
- Compliance with SEBI Insider Trading Regulations.
Price Impact
More from LALPATHLAB